All medical isotopes produced in Petten and their applications - NRG Medical - Public Information Service van NRG (An ECN-KEMA company)

This is the EN-version [List of Public Info] > [Medical applications] > [Medical isotopes produced in Petten]

Medical Isotopes produced in Petten and their applications

Isotope	Half-life	Medical application
Molybdenum-99/ Technetium-99m	2.75 days / 0.25 days	Diagnostic imaging for a broad range of serious medical conditions including oncology -- all areas, cardiology -- heart function and viability, kidney function, brain function, brain disorders, lung function, infection detection, thyroid function, bone disorders
Iodine-131	8.04 days	Therapy isotope for thyroid ablation (hyperthyroidism), thyroid cancer therapy, cancer therapy solid and diffuse tumours, e.g. attached to monoclonal antibodies
Xenon-133	5.25 days	Diagnostic imaging for lung function
Strontium-89	50.5 days	Therapy isotope for metastatic bone pain relief
Iridium-192	73.8 days	Therapy isotope for cancer therapy, e.g. cervical cancer, lung cancer (high dose rate brachytherapy) using remote loaded sources and head and neck cancer, tongue and mouth cancer (low dose rate brachytherapy) using iridioplatinum wires and needles. Preventive therapy isotope for e.g. restenosis prevention in blood vessels using remote loaded sources.
Samarium-153	1.95 days	Therapy isotope for metastatic bone pain relief (palliative care) and in development for treatment of bone cancers. Development isotope for new therapies .
Rhenium-186	3.78 days	Therapy isotope for metastatic bone pain relief. Development isotope for new therapies.
Iodine-125	60.1 days	Therapy isotope for prostate cancer therapy by seed implantation and for eye cancer therapy by ophthalmic applicator.
Yttrium-90	2.67 days	Therapy isotope for treatment of arthritic conditions by synovial joint injection and for metastatic bone pain relief (palliative care).
Erbium-169	9.40 days	Development isotope for new therapies. Therapy isotope for treatment of arthritic conditions by synovial joint injection (smaller joints).
Lutetium-177	6.71 days	Therapy isotope for cancer therapy of solid tumours by injection of labelled peptides.
Holmium-166	1.12 days	Therapy isotope for development of liver cancer treatment by injection of PLA microspheres. Used in clinical trial in Europe of new blood cancer treatment. Development isotope for new therapies.